Immunotherapy for SARS-CoV-2: potential opportunities

Expert Opin Biol Ther. 2020 Oct;20(10):1111-1116. doi: 10.1080/14712598.2020.1807933. Epub 2020 Aug 12.

Authors

Mehrnoosh Pashaei¹, Nima Rezaei^{1

2

3}

Affiliations

¹ Department of Immunology, School of Medicine, Tehran University of Medical Sciences , Tehran, Iran.
² Network of Immunity in Infection, Malignancy and Autoimmunity (NIIMA), Universal Scientific Education and Research Network (USERN) , Tehran, Iran.
³ Research Center for Immunodeficiencies, Children's Medical Center, Tehran University of Medical Sciences , Tehran, Iran.

No abstract available

Keywords: COVID-19; Immunotherapy; monoclonal antibodies; severe acute respiratory syndrome coronavirus 2.

Publication types

Editorial
Comment

MeSH terms

Betacoronavirus*
COVID-19
Coronavirus Infections*
Humans
Immunotherapy
Pandemics*
Pneumonia, Viral*
SARS-CoV-2